Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Valencell

Explore full profile

Bringing wearables to market with today's most accurate biometrics

Raleigh, United StatesFounded 2006Biotech & Life Sciences
Valuation $25–50M Last recorded · 2018
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Valencell and the history behind them.

About Valencell

Valencell specializes in developing highly accurate photoplethysmography (PPG) sensors for wearable technology. These sensors continuously measure heart rate and other biometrics, providing valuable health insights. The company serves both consumer and medical markets, offering solutions that enhance the functionality of wearables and hearables. Valencell's business model revolves around licensing its sensor technology to device manufacturers, thereby generating revenue through licensing fees and royalties. The company operates in the health and wellness sector, focusing on innovations like cuffless blood pressure monitoring. By partnering with various organizations, Valencell aims to enable biometric use cases that improve people's lives.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2006
Headquarters
Raleigh, United States
Employees
16
Open positions
None listed
Dealroom signal
59.1/100
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Intellectual Property, Testing
Technology
Artificial Intelligence, Hardware, Deep Tech, Machine Learning, Computer Vision, Connected Device, Recognition Technology, IoT InternetOfThings
Business model
Manufacturing
Client focus
b2b
Links
WebsiteX

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES EOther financing Jun 2018 $11M $42M TDF Ventures · Sonion · WSJ Joshua Fund —
SERIES DOther financing Mar 2016 $11M $44M TDF Ventures · WSJ Joshua Fund · GII Tech Ventures —
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Valencell website traffic

Latest recorded traffic for Valencell is 190 monthly website visits, down 98.6% over the last three months. Valencell's team grew 0% over the past year.

Latest monthly visits190 3-month web change-98.6% 1-year team growth0%
Monthly website visitsApr 2016–Nov 2025
Explore monthly traffic historyTrack growth over time and compare with peersBook a demo
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
BioBeatBioBeat develops a cutting-edge wearable for continuous non-invasive accurate medical-grade monitoring of vital signs, including continuous blood pressure, saturation, respiratory rate, heart rate, consciousness, cardiac output, stroke volume, body t Petah Tikva, Israel Operational 77 $58M $200M
FluoroPharmaMolecular imaging agents for positron emission tomography, enabling detection and assessment of pathology Boston, United States Operational
CortriumOne easy ECG solution - Set up the patient, upload recording, and order your report Taastrup, Denmark Operational
EstechMedical device manufacturing and distribution company offering products for cardiac surgery San Ramon, United States Acquired
ValidicThe platform-approach to simplifying personal health data -- solutions to derive and analyze meaningful insights from your population Durham, United States Acquired
Pear TherapeuticsPear discovers, develops, and commercializes Prescription Digital Therapeutics to treat diseases with high unmet need Boston, United States Operational
POC Medical Systems Inc.Home - POC Medical Systems Livermore, United States Operational
NeomendBiomedical device company engaged in the development and commercialization of surgical wound healing products Irvine, United States Acquired
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

0 profiles shownExplore the complete relationship graph →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • NC IDEA

Series A3 investors entered at this stage

Series B and later3 investors entered at this stage

  • GII Tech Ventures
  • WSJ Joshua Fund
  • Sonion

Other known investors2 additional known investors

Talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Raleigh HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Valencell on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Valencell’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Request a free trial

Takes under a minute. Already use Dealroom? Log in.